Answer2cancer
Nonprofit profile at a glance
- EIN
- 814885713
- IRS 990-EZ coverage
- 2018–2025
- Forms available
- Form 990-EZ 2025
- Location
- Beaverton, OR, USA
- Phone
- 5032017019
- Rating
- 35
- Verdict
- REVIEW
- Rating confidence
- Moderate
- Sector
- Public Health Program (Includes General Health and Wellness Promotion Services)
Reported finances
- Revenue
- $1
- Expenses
- $10,388
- Assets
- $26,505
- Liabilities
- $10,522
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
4 people listed
Executive titles in this filing
- Dianne J Danowski-Smith (President)
People named in this filing
- Dianne J Danowski-Smith (President)
- Andrew D Smith (CFO)
- Elaine Denning (Secretary)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Answer2Cancer, Inc. is by and for patients who, while going through cancer treatments, realized they didn't know what they didn't know. Those undergoing treatment (and their caregivers) know there is so much to know. Answer2Cancer, Inc. has been created to help patients and their caregivers/helpers overcome the challenges of treatments and learn helpful, healthful survivor strategies.
What it reported doing in 2025
2025-Challenging year of reaching out to make deeper partnerships, attended Advocacy Day in Salem. Seeking viable sponsors for 2026 events. Pharmaceutical companies are changing their models and it is more difficult to obtain partnerships for events and programs. Cuts to Federal funding and stronger competition for dollars is creating a challenging environment. The Focus for this year was to develop relationships with partners for smaller events with smaller costs and larger impact. These take time to develop and move through the process. In 2025 A2C was invited to participate in the Advocacy activities with Vertex at the Oregon Capitol in March of 2025. Goal for 2026 is focused on a potential partnership and A2C event in Eugene, in cooperation with the Salem Cancer Community, Oregon Oncology Specialists and Willamette Valley Cancer Institute in Eugene/Lane County.
Operating model
- Revenue model
- Investment-supported. 100% of the money available for current operations came from recurring investment income.
- Distribution model
- No current program activity. The filing reports no program spending for the current year.
The verdict
REVIEW - The filed numbers largely add up. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.
Rating breakdown
- Financial Efficiency: 0
- Transparency & Controls: 82
- Sustainability: 29
- Growth: 20
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 0%; rating input score 0
- Program expense ratio: 0%; rating input score 0
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: -1,038,700%; rating input score 0; 0th percentile among comparable filings
- Total-asset coverage ratio: 2.55; rating input score 71; 71st percentile among comparable filings
- Liabilities to assets ratio: 0.4; rating input score 9; 9th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -71.9% per year; rating input score 0; 6th percentile among comparable filings
- Revenue growth: -53.9% per year; rating input score 0; 6th percentile among comparable filings
- Asset growth: 9.4% per year; rating input score 100; 69th percentile among comparable filings
Details
- Where the money goes: 0% of revenue deployed · 0% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 5 filed program accomplishments
- Leadership: top reported pay $0 · 4 people listed
- Consistency: 9 of 9 current checks pass
- Schedules: 2 filed schedules
- Filing history: 6 filing years from 2018 to 2025
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Financial Efficiency: Mission deployment rate scored 0/100.
- High — Financial Efficiency: Program expense ratio scored 0/100.
- High — Sustainability: Operating margin scored 0/100.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Liabilities to assets ratio scored 9/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.